Literature DB >> 23558966

XRCC3 T241M polymorphism is associated risk of hepatocellular carcinoma in the Chinese.

Chibo Liu1, Haibao Wang.   

Abstract

The X-ray repair cross-complementing group 3 (XRCC3) gene has been suggested to play an important role in the pathogenesis of hepatocellular carcinoma (HCC). However, the results have been inconsistent. In this study, we performed a meta-analysis to clarify the association of XRCC3 Thr241Met variant with HCC. The published literature from PubMed, Chinese National Knowledge Infrastructure, and Wan Fang data was retrieved. Pooled odds ratio (OR) with 95 % confidence interval (CI) was calculated using fixed or random effects model. A total of five studies (1,531 HCC cancer cases and 1,952 controls) for XRCC3 Thr241Met variant were included in the meta-analysis. The meta-analysis showed that XRCC3 Thr241Met variant was associated with HCC risk under homogeneous codominant model (OR = 3.99, 95 % CI = 1.74-9.13) and recessive model (OR = 5.22, 95 % CI = 3.65-7.48), but not under heterogeneous codominant model (OR = 1.18, 95 % CI = 0.68-2.05) and dominant model (OR = 1.37, 95 % CI = 0.73-2.57). Subgroup analysis by ethnicity suggested that XRCC3 Thr241Met variant was associated with HCC risk in Chinese population, but not in Pakistani population. The present meta-analysis supported the positive association of XRCC3 Thr241Met variant with HCC in the Chinese. Further large-scale studies with the consideration for gene-gene/gene-environment interactions should be conducted to investigate the association.

Entities:  

Mesh:

Substances:

Year:  2013        PMID: 23558966     DOI: 10.1007/s13277-013-0765-4

Source DB:  PubMed          Journal:  Tumour Biol        ISSN: 1010-4283


  18 in total

1.  DNA repair capacity, DNA-strand break repair gene polymorphisms, and the incidence of hepatocellular carcinoma in southwestern Guangxi of China.

Authors:  Xiaoyun Zeng; Shun Liu; Hongping Yu; Long Ji; Longman Li; Jinmei Huang; Hua Bai; Xiaoqiang Qiu
Journal:  DNA Cell Biol       Date:  2012-06-12       Impact factor: 3.311

2.  Relationship between XRCC3 T241M polymorphism and gastric cancer risk: a meta-analysis.

Authors:  Fang Fang; Jia Wang; Lei Yao; Xiao-Jia Yu; Lu Yu; Long Yu
Journal:  Med Oncol       Date:  2010-06-12       Impact factor: 3.064

3.  Meta-analysis in clinical trials.

Authors:  R DerSimonian; N Laird
Journal:  Control Clin Trials       Date:  1986-09

4.  Study on the DNA repair gene XRCC1 and XRCC3 polymorphism in prediction and prognosis of hepatocellular carcinoma risk.

Authors:  Xuechang Han; Qunzhi Xing; Yu Li; Junjun Sun; Huihui Ji; Pan Huazheng; Liang Jun
Journal:  Hepatogastroenterology       Date:  2012-10

5.  XRCC3 T241M polymorphism and bladder cancer risk: a meta-analysis.

Authors:  Fuyuan Li; Chunxiang Li; Zheng Jiang; Ning Ma; Xu Gao
Journal:  Urology       Date:  2010-10-13       Impact factor: 2.649

6.  Association between the XRCC3 T241M polymorphism and head and neck cancer susceptibility: a meta-analysis of case-control studies.

Authors:  Qing-Hua Yin; Chuan Liu; Lian Li; Xu-Yu Zu; Ya-Jie Wang
Journal:  Asian Pac J Cancer Prev       Date:  2012

7.  Association of XRCC1, XRCC3, and XPD genetic polymorphism with an increased risk of hepatocellular carcinoma because of the hepatitis B and C virus.

Authors:  Asma Gulnaz; Ali H Sayyed; Farah Amin; Abrar ul Haq Khan; Muhammad A Aslam; Rehan S Shaikh; Muhammad Ali
Journal:  Eur J Gastroenterol Hepatol       Date:  2013-02       Impact factor: 2.566

8.  [Association of the Thr241Met polymorphism of DNA repair gene XRCC3 with genetic susceptibility to AFB1-related hepatocellular carcinoma in Guangxi population].

Authors:  Xi-dai Long; Yun Ma; Zhuo-lin Deng; Yong-zhi Huang; Ni-bo Wei
Journal:  Zhonghua Yi Xue Yi Chuan Xue Za Zhi       Date:  2008-06

9.  The polymorphism of XRCC3 codon 241 and AFB1-related hepatocellular carcinoma in Guangxi population, China.

Authors:  Xi Dai Long; Yun Ma; De Ying Qu; Yun Guang Liu; Zhao Quan Huang; Yong Zhi Huang; Zhong Hui Lin; Ni Bo Wei; Shu Chun Zhou
Journal:  Ann Epidemiol       Date:  2008-05-27       Impact factor: 3.797

Review 10.  Hepatocellular cancer: a guide for the internist.

Authors:  Sameer Parikh; David Hyman
Journal:  Am J Med       Date:  2007-03       Impact factor: 4.965

View more
  4 in total

1.  Association between XRCC3 Thr241Met polymorphism and nasopharyngeal carcinoma risk: evidence from a large-scale case-control study and a meta-analysis.

Authors:  Qian Cui; Xiao-Yu Zuo; Yi-Fan Lian; Qi-Sheng Feng; Yun-Fei Xia; Cai-Yun He; Li-Zhen Chen; Wei-Hua Jia; Hai-Qiang Mai; Yi-Xin Zeng; Jin-Xin Bei
Journal:  Tumour Biol       Date:  2016-09-17

Review 2.  Associations between Cox-2 rs20417 and rs5275 polymorphisms and the risk of hepatocellular carcinoma: a meta analysis.

Authors:  Hexing Wu; Xiangwei Wu; Guoxing Wan; Shijie Zhang
Journal:  Int J Clin Exp Pathol       Date:  2014-09-15

Review 3.  Association between PNPLA3 rs738409 polymorphisms and risk of hepatocellular carcinoma and its development in patients with cirrhosis: a meta-analysis.

Authors:  Shijie Zhang; Hexing Wu; Xiangwei Wu; Webo Lian; Yanchao Wang; Xiaozhao Zhang; Xinyu Peng
Journal:  Int J Clin Exp Med       Date:  2015-05-15

4.  Haplotype-based case-control study of DNA repair gene XRCC3 and hepatocellular carcinoma risk in a Chinese population.

Authors:  Hong-Chun Luo; Hong-Bin Zhang; Xiao-Juan Xin; Wen-Xiang Huang
Journal:  Tumour Biol       Date:  2013-12-05
  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.